These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 23770230)
21. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency. Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1. Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320 [TBL] [Abstract][Full Text] [Related]
23. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion. Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182 [TBL] [Abstract][Full Text] [Related]
24. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis. Kitching AR; Turner AL; O'Sullivan KM; Dewerchin M; Lijnen HR J Thromb Haemost; 2003 Sep; 1(9):1992-9. PubMed ID: 12941042 [TBL] [Abstract][Full Text] [Related]
25. Characterization and targeting of the murine alpha2-antiplasmin gene. Okada K; Lijnen HR; Dewerchin M; Belayew A; Matsuo O; Collen D; Bernaerts R Thromb Haemost; 1997 Sep; 78(3):1104-10. PubMed ID: 9308761 [TBL] [Abstract][Full Text] [Related]
26. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781 [TBL] [Abstract][Full Text] [Related]
27. The hyperfibrinolytic state of mice with combined thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 gene deficiency is critically dependent on TAFI deficiency. Vercauteren E; Peeters M; Hoylaerts MF; Lijnen HR; Meijers JC; Declerck PJ; Gils A J Thromb Haemost; 2012 Dec; 10(12):2555-62. PubMed ID: 23083123 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice. Wang H; Vohra BP; Zhang Y; Heuckeroth RO Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054 [TBL] [Abstract][Full Text] [Related]
29. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study. Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859 [TBL] [Abstract][Full Text] [Related]
30. Plasmin system regulation in an ovalbumin-induced rat model of asthma. Kucharewicz I; Mogielnicki A; Kasacka I; Buczko W; Bodzenta-Łukaszyk A Int Arch Allergy Immunol; 2008; 147(3):190-6. PubMed ID: 18594148 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis. Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404 [TBL] [Abstract][Full Text] [Related]
33. Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling. Hou Y; Okada K; Okamoto C; Ueshima S; Matsuo O Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1257-62. PubMed ID: 18436805 [TBL] [Abstract][Full Text] [Related]
34. Fracture healing in mice deficient in plasminogen activator inhibitor-1. Rundle CH; Wang X; Wergedal JE; Mohan S; Lau KH Calcif Tissue Int; 2008 Oct; 83(4):276-84. PubMed ID: 18820962 [TBL] [Abstract][Full Text] [Related]
35. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade. Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922 [TBL] [Abstract][Full Text] [Related]
36. α₂-Antiplasmin is involved in bone loss induced by ovariectomy in mice. Shiomi A; Kawao N; Yano M; Okada K; Tamura Y; Okumoto K; Matsuo O; Akagi M; Kaji H Bone; 2015 Oct; 79():233-41. PubMed ID: 26094563 [TBL] [Abstract][Full Text] [Related]
37. Role of angiotensin and the clock system in the circadian regulation of plasminogen activator inhibitor-1. Masuda Y; Emoto N; Nonaka H; Yagita K; Todo T; Okamura H; Yokoyama M; Hirata K Kobe J Med Sci; 2009 Mar; 54(6):E264-71. PubMed ID: 19628967 [TBL] [Abstract][Full Text] [Related]
38. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury. Abderrahmani R; François A; Buard V; Benderitter M; Sabourin JC; Crandall DL; Milliat F Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):942-8. PubMed ID: 19480973 [TBL] [Abstract][Full Text] [Related]
39. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Dimova EY; Kietzmann T Thromb Haemost; 2008 Dec; 100(6):992-1006. PubMed ID: 19132222 [TBL] [Abstract][Full Text] [Related]
40. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice. Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]